- Home
- CRGX vs HNVR Comparison
CRGX vs HNVR Comparison
Compare CRGX & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- HNVR
- Stock Information
- Founded
- CRGX 2021
- HNVR 2008
- Country
- CRGX United States
- HNVR United States
- Employees
- CRGX N/A
- HNVR N/A
- Industry
- CRGX
- HNVR Commercial Banks
- Sector
- CRGX
- HNVR Finance
- Exchange
- CRGX Nasdaq
- HNVR Nasdaq
- Market Cap
- CRGX 207.5M
- HNVR 167.7M
- IPO Year
- CRGX 2023
- HNVR 2022
- Fundamental
- Price
- CRGX $4.54
- HNVR $21.51
- Analyst Decision
- CRGX Hold
- HNVR Buy
- Analyst Count
- CRGX 7
- HNVR 2
- Target Price
- CRGX $5.33
- HNVR $23.75
- AVG Volume (30 Days)
- CRGX 1.7M
- HNVR 12.4K
- Earning Date
- CRGX 08-06-2025
- HNVR 07-23-2025
- Dividend Yield
- CRGX N/A
- HNVR 1.86%
- EPS Growth
- CRGX N/A
- HNVR N/A
- EPS
- CRGX N/A
- HNVR 1.53
- Revenue
- CRGX N/A
- HNVR $68,211,000.00
- Revenue This Year
- CRGX N/A
- HNVR N/A
- Revenue Next Year
- CRGX N/A
- HNVR $13.97
- P/E Ratio
- CRGX N/A
- HNVR $14.08
- Revenue Growth
- CRGX N/A
- HNVR 14.14
- 52 Week Low
- CRGX $3.00
- HNVR $16.71
- 52 Week High
- CRGX $25.45
- HNVR $27.14
- Technical
- Relative Strength Index (RSI)
- CRGX 59.56
- HNVR 46.65
- Support Level
- CRGX $4.45
- HNVR $20.88
- Resistance Level
- CRGX $4.51
- HNVR $22.40
- Average True Range (ATR)
- CRGX 0.04
- HNVR 0.57
- MACD
- CRGX -0.00
- HNVR 0.08
- Stochastic Oscillator
- CRGX 76.00
- HNVR 47.79
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.